Literature DB >> 22135382

Epigenetic augmentation of the macrophage inflammatory protein 2/C-X-C chemokine receptor type 2 axis through histone H3 acetylation in injured peripheral nerves elicits neuropathic pain.

Norikazu Kiguchi1, Yuka Kobayashi, Takehiko Maeda, Yohji Fukazawa, Kazuo Tohya, Michio Kimura, Shiroh Kishioka.   

Abstract

Although there is growing evidence showing that the involvement of chemokines in the pathogenesis of neuropathic pain is associated with neuroinflammation, the details are unclear. We investigated the C-X-C chemokine ligand type 2 [macrophage inflammatory protein 2 (MIP-2)]/C-X-C chemokine receptor type 2 (CXCR2) axis and epigenetic regulation of these molecules in neuropathic pain after peripheral nerve injury. Expression of MIP-2 and CXCR2 were up-regulated and localized on accumulated neutrophils and macrophages in the injured sciatic nerve (SCN) after partial sciatic nerve ligation (PSL). Perineural injection of MIP-2-neutralizing antibody (anti-MIP-2) or the CXCR2 antagonist N-(2-bromophenyl)-N'-(2-hydroxy-4-nitrophenyl)urea (SB225002) prevented PSL-induced tactile allodynia and thermal hyperalgesia. Perineural injection of recombinant MIP-2 elicited neuropathic pain-like behaviors. Anti-MIP-2 suppressed neutrophil accumulation in the SCN after PSL. Neutrophil depletion by intraperitoneal injection of Ly6G antibody attenuated PSL-induced neuropathic pain. Both anti-MIP-2 and SB225002 suppressed up-regulation of inflammatory cytokines and chemokines in the injured SCN. In addition, acetylation of histone H3 [lysine (Lys9)-acetylated histone H3 (AcK9-H3)] on the promoter region of MIP-2 and CXCR2 was increased in the injured SCN after PSL. Expression of AcK9-H3 was observed in the nuclei of neutrophils and macrophages surrounding the epineurium. Administration of the histone acetyltransferase inhibitor anacardic acid suppressed the up-regulation of MIP-2 and CXCR2 in the SCN after PSL and resulted in the prevention of PSL-induced neuropathic pain. Taken together, these results show that augmentation of the MIP-2/CXCR2 axis by hyperacetylation of histone H3 on the promoter region of MIP-2 and CXCR2 located in the injured peripheral nerve elicits chronic neuroinflammation through neutrophil accumulation, leading to neuropathic pain.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22135382     DOI: 10.1124/jpet.111.187724

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  36 in total

Review 1.  [Epigenetics and pain].

Authors:  E Niederberger
Journal:  Anaesthesist       Date:  2014-01       Impact factor: 1.041

Review 2.  Drugging the pain epigenome.

Authors:  Ellen Niederberger; Eduard Resch; Michael J Parnham; Gerd Geisslinger
Journal:  Nat Rev Neurol       Date:  2017-05-26       Impact factor: 42.937

Review 3.  Epigenetics and the transition from acute to chronic pain.

Authors:  Thomas Buchheit; Thomas Van de Ven; Andrew Shaw
Journal:  Pain Med       Date:  2012-09-14       Impact factor: 3.750

4.  Macrophage-T cell interactions mediate neuropathic pain through the glucocorticoid-induced tumor necrosis factor ligand system.

Authors:  Yuka Kobayashi; Norikazu Kiguchi; Yohji Fukazawa; Fumihiro Saika; Takehiko Maeda; Shiroh Kishioka
Journal:  J Biol Chem       Date:  2015-03-18       Impact factor: 5.157

Review 5.  Nociceptor Sensory Neuron-Immune Interactions in Pain and Inflammation.

Authors:  Felipe A Pinho-Ribeiro; Waldiceu A Verri; Isaac M Chiu
Journal:  Trends Immunol       Date:  2016-10-25       Impact factor: 16.687

Review 6.  Epigenetic regulation of chronic pain.

Authors:  Lingli Liang; Brianna Marie Lutz; Alex Bekker; Yuan-Xiang Tao
Journal:  Epigenomics       Date:  2015       Impact factor: 4.778

7.  Further evidence on a role of chemokines in injury-related pain hypersensitivity: commentary on a paper by Saika et al. (2012, this issue).

Authors:  Ke Ren
Journal:  Eur J Pain       Date:  2012-05-21       Impact factor: 3.931

8.  EZH2 regulates spinal neuroinflammation in rats with neuropathic pain.

Authors:  Ruchi Yadav; Han-Rong Weng
Journal:  Neuroscience       Date:  2017-02-28       Impact factor: 3.590

9.  Effect of histone deacetylase inhibitor JNJ-26481585 in pain.

Authors:  Kathryn E Capasso; Melissa T Manners; Rehman A Quershi; Yuzhen Tian; Ruby Gao; Huijuan Hu; James E Barrett; Ahmet Sacan; Seena K Ajit
Journal:  J Mol Neurosci       Date:  2014-08-02       Impact factor: 3.444

Review 10.  Epigenetic regulation of persistent pain.

Authors:  Guang Bai; Ke Ren; Ronald Dubner
Journal:  Transl Res       Date:  2014-05-29       Impact factor: 7.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.